Clinical Trials in Philadelphia

Showing 8861-8880 of 15,860 trials

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

NCT04089761

Nerivio™ is an FDA-authorized remote electrical neuromodulation (REN) device for the acute treatment of migraine with or without aura in patients 18 years old or above who do not have chronic migraine. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. This is a prospective, single arm, open label, multicenter trial of the safety and efficacy of Nerivio™ for the acute treatment of migraine in adolescents The study will be conducted in three phases: Phase I - Run-in: Phase II - Treatment phase: Phase III (optional) - Free-use

Acute Migraine

Theranica60 participantsStarted Oct 2019

Aurora, Colorado, United States • Hialeah, Florida, United States • Miami, Florida, United States +9 more locations

WITHDRAWNNA< 1 mile

IOP and Medication Reduction in MIGS Procedures

NCT04202510

The primary objective of this research is to compare the efficacy of trabecular minimally invasive glaucoma surgery (MIGS) devices (iStent vs iStent Inject vs Hydrus) for intra ocular pressure (IOP) and anti-glaucoma medication reduction in open angle glaucoma.

Open Angle GlaucomaPrimary Open Angle GlaucomaPigmentary Glaucoma+1 more

Wills EyeStarted Jan 2020

Philadelphia, Pennsylvania, United States

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

IOP and Medication Reduction in MIGS Procedures

Find Trials by Condition in Philadelphia

Atorvastatin Three Year Pediatric Study

Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma

Celebrex In Acute Gouty Arthritis Study

Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma

Safety and Tolerability of PNT001 in Healthy Adults

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Self-directed Video Versus Instructor-based Neonatal Resuscitation Training

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients

NAPLS Omega-3 Fatty Acid Versus Placebo Study

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

Hemodialysis Access Surveillance Evaluation Study

Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection